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 Summary
	   Evaluation	 of	 vascular	 reactivity	 becomes	 increasingly	more	 often	 applied	 in	 assessing	vascular	
susceptibility	 to	 atherosclerosis	 and	 vascular	 damage	 in	 diabetes.	 “Gold	 standard”	 test	 for	
vasodilation	 assessment	 includes	 administration	 of	 exogenous	nitric	 oxide	 (NO)	 donor.	 The	 aim	
of	this	work	was	to	analyze	the	course	and	effect	of	the	test	 in	type	1	diabetes	and	non-diabetes	
subjects	in	different	age	groups.	
	 	 71	 healthy	 men	 and	 45	 male	 patients	 with	 type	 1	 diabetes	 were	 examined.	 Evaluation	 of	
hemodynamic	reaction	was	conducted	with	the	means	of	ultrasound	color	Doppler	examination.	
	 	 It	has	been	demonstrated	that	the	degree	of	vascular	reaction	to	the	administration	of	NO	reduces	
with	 age:	 in	 subjects	<30	 years	 old	 the	 change	 in	 early	 diastolic	 velocity	 (Vr1)	 is	 236%,	while	
in	 those	>45	years	 old	 102%.	The	 response	 to	 stimulus	 occurred	 at	 different	 times	 in	 different	
subgroups.	After	NO	administration	 the	 reaction	 occurs	most	 rapidly	 in	 young	men	 (70-130	 sec.)	
and	the	slowest	reaction	was	noted	in	healthy	subjects	aged	<46	years	(100-230	sec.).	Changes	are	
more	pronounced	 in	patients	with	diabetes,	 particularly	 in	 subjects	<30	years,	with	 the	 change	
in	Vr1	 158%,	whilst	 in	 those	 aged	>45	 years	 it	was	merely	 78%.	 The	 reaction	 in	 the	 group	 of	
patients	with	diabetes	occurred	in	those	aged	<	30	years	(100-160	sec.),	and	in	subjects	>46	years	
(120-240	sec.).	These	differences	were	statistically	significant.	
	 	 Reliable	evaluation	of	vascular	reaction	to	the	action	of	pharmacological	stimulus	requires	constant	
spectral	 analysis.	 Age-	 and	 co-morbidities	 related	 modifications	 to	 pharmacological	 test	 are	
justified,	especially	in	elderly	subjects	and	in	patients	with	diabetes.
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Background
Evaluation	 of	 vascular	 reactivity	 becomes	 increasing-
ly	more	 often	 applied	 in	 prognosing	 individual	 suscepti-
bility	 to	 the	 development	 of	 the	 atherosclerosis	 process	
[1-3].	 Abundant	 evidence	 proves	 that	 vascular	 respon-
se	 to	 stimuli	 in	 the	 form	of	 temporary	 ischaemia	 and	 to	
the	administered	nitric	oxide	(NO)	may	reflect	the	degree	
of	 arterial	 damage,	 also	 observed	 in	 diabetes	 and	meta-
bolic	 disorders	 [4-6].	 Diagnostics	 may	 be	 also	 conduc-
ted	 at	 the	 preclinical	 stage	 of	 the	 disease,	 in	 the	 period	
when	 changes	 are	 still	morphologically	 imperceptible	 in	
image	examination	[6,	7].	The	fundamental	test	to	specify	
vasodilative	 potential	 consists	 of	 sublingual	 administra-
tion	of	exogenous	NO	donor,	typically	nitroglycerine	(NTG)	
preparation	 and	 further	 in	 assessing	 relative	 dilation	 of	
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peripheral	vessels	based	on	the	ultrasound	Doppler	image.	
The	dilatation	 is	 independent	 of	 the	 endothelium	activi-
ty	 (non-endothelium	 dependent	 dilatation)	 and	 is	 com-
parable	 to	 the	 dilatation	 observed	 in	 the	 function	 tests	
revealing	 intrinsic	 endothelium	activity,	 i.e.	 the	 dilation	
dependent	 on	 the	 secretive	 function	 of	 the	 endothelium	
(flow	 mediated	 dilatation,	 FMD)	[1].	 Methodology	 of	
conducting	 functional	 tests	 presented	 in	 literature	 focu-
ses	 on	 recording	 the	 vasodilative	 effect,	 i.e.	 the	 changes	
in	 the	 vessel	 diameter	 at	 rest	 in	 response	 to	 stimulus.	
Conducting	 an	 arbitrary	 functional	 test	with	 the	 excep-
tion	of	the	changes	in	the	diameter	of	the	vessel	parallelly	
generates	changes	 in	 the	Doppler	 spectral	waveform,	 i.e.	
the	hemodynamic	 effect	 relevant	 to	 the	 test	 [8].	Changes	
in	 the	spectrum	display	two	characteristic	hemodynamic	
response	patterns:	one	induced	by	the	increased	flow	and	
the	 other	 typical	 of	 the	 test	 independent	 of	 endothelium	
activity.	
The	 aim	 of	 this	 work	 was	 to	 analyse	 the	 effect	 of	 oral	
administration	of	NO	donor	in	different	age	groups	of	male	
subjects	with	different	metabolic	 status	which	may	affect	
vasculature,	therefore	the	degree	and	progression	of	hemo-
dynamic	response	were	analysed	in	healthy	subjects	and	in	
patients	with	type	1	diabetes.	
Materials
Two	groups	of	 subjects	were	enrolled:	healthy	 individuals	
and	patients	with	type	1	diabetes.	The	group	of	volunteers	
(group	 1)	 consisted	 of	 71	 healthy	non-smoking	men	with	
unremarkable	medical	 history	 and	 low	vascular	 risk	 eva-
luated	according	to	the	SCORE	scale	 (Systematic	Coronary	
Risk	Evaluation,	2003)	[8].	The	group	of	patients	with	type	
1	diabetes	(group	II)	consisted	of	45	men	treated	with	insu-
lin	preparations,	with	stable	
Subjects	in	both	groups	were	divided	into	3	age	subgroups	
(A,	B,	C):	
–	group	A:	aged	from	18	to	30	years	old,
–	group	B:	aged	from	31	to	45	years	old,
–	group	C:	aged	from	46	to	60	years	old.
As	expected,	patients	with	diabetes	displayed	significantly	
higher	values	 of	 the	 sudden	vascular	 incident	 index	 (sub-
groups:	 1A	 and	1B<1%,	 subgroup:	 1C	 -	 1%,	 2A	<	1%,	 2B	
1-4%	and	2C	2-12%).
Demographic	 and	 clinical	 data	 and	 the	distribution	of	 the	
risk	 of	 the	 cardiovascular	 incident	 occurrence	 are	 shown	
in	table	1.
Methods
The	evaluation	of	vascular	 reactivity	 (hemodynamic	efect)	
was	 conducted	 based	 on	 ultrasound	 examination	 with	
colour	waveform	 imaging	 (USG-CD).	The	General	Electric	
Logiq	7	system	with	linear,	broadband	probe	of	10-14	MHz	
frequency	(type	M12L)	was	used.	The	operating	system	ena-
bles	recording	of	 the	complete	examination	 in	the	form	of	
initial	data,	as	well	as	performs	secondary	analysis	(measu-
rements,	 image	 enlargement,	 filtration	of	 the	Doppler	 sig-
nal,	 changes	 in	 angle	 correction,	 forms	of	 recording	 spec-
tral	wavelength).	
The	 technique	 of	 conducting	pharmacological	 test	 confor-
med	with	 the	 standards	 established	 in	 the	 literature	 [1,9-
11].	The	examination	was	carried	out	on	the	right	brachial	
artery,	 in	 patients	 lying	 supine.	The	 arteries	were	 asses-
sed	 in	 the	 area	 of	 elbow	 joint,	 above	 the	 articular	 space,	
to	 obtain	 optimum	conditions	 in	 order	 to	 record	 spectral	
waveform	using	 the	Doppler	 pulsation	wave	 (PW)	 techni-
que.	The	impact	of	functional	test	on	the	vessel	was	mea-
sured	based	upon	 the	 changes	 in	values	 of	measurements	
carried	out	at	baseline	and	after	the	test.
Hemodynamic	effect	was	analysed	based	upon	the	values	of	
blood	flow	velocity	in	four	characteristic	waves	of	Doppler	
spectrum:
–		at	 the	 systolic	 stage	 -	 velocity	measurement:	maximum	
systolic	(Vs),	
–		at	the	diastolic	stage	-	velocity	measurement:	early	diasto-
lic	(Vr1),	maximum	diastolic	(Vr2)	and	late	diastolic	(Vr3).
At	 the	 first	 stage	 of	 the	 examination	parameters	 of	 blood	
flow	at	rest	were	recorded	(time	0,	t0).	At	the	second	stage	
Table 1. Material: Demographic and clinical data in the studied group.
Studied groups
Group I Group II
A B C A B C
Age intervals (years) 18÷30 31÷45 46÷60 18÷30 31÷45 46÷60 
Number of subjects in the group 21 21 29 15 15 15
Average age of the group 24,1 38,5 52,2 24,6 39,0 52,1
Mean cholesterol level (mmol/l) 4,5 4,6 4,6 4,6 5,2 5,5
Mean glucose level in the blood (mmol/l) 5,4 5,2 5,6 6,2 6,4 6,8
Mean values of systolic blood pressure (mmHg) 118 120 122 119 121 126
Risk of cardiovascular incident SCORE (%) 0 0 <1% <1% 1-4% 2-12%
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one	dose	of	the	NO	donor	in	aerosol	(400	µg,	Nitromint	pre-
paration)	was	administered	 sublingually,	 followed	by	 con-
tinuous	 recording	 of	 spectral	waveform	 for	 360	 seconds	
(6	minutes).	Velocities	were	analysed	every	15	sec.	Relative	
changes	 in	 velocity	 values	were	 accepted	 for	 analysis	 as	
reflecting	the	degree	of	vascular	response.	
Mean	values,	 standard	 deviation	 (SD)	 and	 standard	 error	
(SE)	were	calculated	for	all	groups.	As	the	distributions	of	
the	measured	parameters	 did	not	differ	 significantly	 from	
the	normal	distribution,	t-Student	test	was	used	to	compa-
re	parameters	for	independent	tests.
Results
High-resistance	 flow	 is	 characteristic	 of	 brachial	 arteries.	
Spectral	waveform	of	 such	nature	was	 initially	 registered	
in	all	subjects	 (Fig.	1).	 In	both	groups	hemodynamic	effect	
of	 the	 test	was	 observed	 as	 the	 increase	 in	 the	 early	dia-
stolic	velocity	 (Vr1),	which	was	reflected	 in	 the	deepening	
of	 the	negative	wave	 of	 the	Doppler	 spectrum.	The	wave	
corresponds	with	 the	 intracardial	 flow	wave	 closing	 the	
aortic	valve	(Fig.	2).	No	significant	differences	were	obser-
ved	in	the	remaining	parameters	of	the	spectral	waveforms	
(Vs,	Vr2	and	Vr3).	
In	group	I	changes	of	velocity	Vr1	were	statistically	sig-
nificant,	and	the	mean	difference	for	all	groups	was	20,9	
cm/s	(difference	of	approx.	170%);	detailed	data	depicting	
the	 scales	of	hemodynamic	effect	of	 the	NO	 test	 and	 its	
progression	 in	 time	are	presented	 in	 table	 2.	 Significant	
differences	 were	 observed	 in	 changes	 of	 early	 diasto-
lic	 velocity	 (Vr1)	 in	 all	 age	 groups.	The	 decrease	 in	 the	
reaction	with	 age	 (the	 differences	 between	 the	 IA	 sub-
group	and	groups	IB	and	IC	was	statistically	significant)	
was	 a	 frequent	 phenomenon.	 In	 the	 group	 of	 patients	
with	diabetes	(group	II)	the	increase	in	velocity	Vr1	was	
also	observed	in	response	to	NO.	The	recorded	increase	in	
velocity	Vr1	was	smaller	 than	 in	group	I,	but	also	stati-
stically	significant	–	the	average	difference	was	13,9	cm/
s	 (difference	 of	 approx.	 104%).	 In	 the	 group	 of	 patients	
with	 diabetes	 differences	 in	 changes	 of	 velocity	Vr1	 in	
separate	age	groups	were	noted.	The	decrease	in	hemody-
namic	effect	with	age	was	observed	(differences	between	
group	 IIA	 and	 groups	 IIB	 and	 IIC	 were	 statistically	
significant).	
In	group	I	hemodynamic	effect	of	the	test	achieved	its	peak	
value	within	70-230	seconds	after	the	drug	administration.	
It	was	most	 rapid	 in	 subgroup	 IA,	within	70-130	seconds,	
and	in	subgroup	IB	between	90	and	195	second.	Noticeably	
slower	response	was	observed	in	subgroup	IC,	after	approx.	
100-230	 sec.	 In	 group	 II	 the	 greatest	 hemodynamic	 effect	
occurred	within	 100-240	 seconds	 after	 the	 drug	 adminis-
tration.	Most	 rapidly	 in	 subgroup	 IIA,	 after	 110-170	 sec-
onds,	 noticeably	 slower	 in	 subgroups	 II	B	 and	 IIC,	where	
mean	was	110-210	and	120-240	seconds.	Differences	in	the	
reaction	time	between	subgroups	IIA,	IIB	and	IIC	were	sta-
tistically	significant.	
Discussion
Function	tests	evaluating	vascular	reactivity	to	various	stimuli	
are	increasingly	applied	in	the	diagnostics	of	vascular	system	
[1-6,	13,	14].	Endothelium-derived	nitric	 oxide	 is	 one	 of	 the	
most	powerful	vasodilators	responsible	for	physiological	blood	
flow	 in	 human	 organism.	 Pharmacological	 tests	 involving	
administering	NO	donor	 that	 exceeds	 secretive	 capability	 of	
the	endothelium	serve	to	reveal	the	dilative	functional	reserve	
of	 the	vascular	wall.	Results	 of	 tests	 revealing	 endothelium	
activity	may	be	interpreted	more	fully	against	the	background	
of	pharmacological	test	results	[1,	16,	17].	The	action	of	nitric	
oxide	consists	in	triggering	the	dilation	of	smooth	muscles	in	
vascular	walls	and	in	decreasing	peripheral	resistance	[17,	18].	
The	consequence	of	 increasing	the	relaxation	of	 the	vascular	
wall	is	the	rise	of	early	diastolic	velocity	(Vr1).	
Table 2.  Results: Progression of the vasodilative reaction after the 
administration of NO.
Studied 
group
Decrease in Vr1after NO 
(cm/s)
Mean max reaction time 
and range (s)
I
A -28,4 102 (70-130)
B -20,2 134 (90-195)
C -14,2 155 (100-230)
II
A -16,9 134 (100-160)
B -12,7 158 (110-210)
C -12,1 174 (120-240)
Figure 1.  Recording of the resting spectral waveform in the brachial 
artery.
Figure 2.  Spectral waveform in the brachial artery after the action 
of pharmacological stimulus. Noticeable increase in early 
diastolic velocity. 
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The	protocol	 of	 conducting	 pharamcological	 test	 establis-
hed	 in	 literature	 assumes	 taking	measurement	 of	 the	 test	
(vasodilative)	effect	at	approx.	90	second	after	the	applica-
tion	of	NTG	dose	less	frequently	in	the	consecutive,	arbitra-
rily	 assumed	periods	 [10,	 15,	 16].	 Presented	 results	 prove	
that	such	protocol	may	 lead	to	unreliable	results,	particu-
larly	 in	 the	 elderly,	 in	whom	 the	 response	 to	 stimulus	 is	
delayed.	The	prompt	response	of	vascular	system	in	youn-
ger	subjects	may	result	from	better	preparation	distribution	
by	 the	 circulatory	 system,	more	 efficient	NO	diffusion	 in	
tissues,	high	vascular	flexibility	and	more	efficient	autore-
gulatory	mechanisms	on	the	level	of	capillaries	[1].	
Hence,	it	seems	purposeful	to	modify	the	protocol	of	phar-
macological	 test	with	 exogenous	NO.	The	obtained	 results	
depicting	the	change	in	hemodynamic	effect	with	age	both	
in	the	group	of	volunteers	and	in	patients	with	type	1	dia-
betes	 are	 similar	 to	 variability	 of	 the	 vasodilative	 effect	
in	 comparable	groups	most	widely	discussed	 in	 literature.	
This	 similarity	 suggests	 depicting	 the	 same	 phenomenon	
dependent	on	the	relaxation	of	the	muscular	coat	of	arterial	
vessel	walls.	Noticeably	higher	variability	of	recorded	velo-
cities	Vr1	facilitate	these	measurements	and	yields	reliable	
results.	 Individually	 differentiated	 time	 of	 the	 occurren-
ce	 of	 vascular	 response	 requires	 continuous	 recording	 of	
the	 progression	 of	 pharmacological	 test	 between	 1	 and	 6	
minute	 and	 secondary	data	 analysis	with	 regard	 to	 valu-
es	obtained	in	separate	age	groups.	The	optimal	procedure	
involves	 spectral	 analysis	 enabling	 determination	 of	 the	
maximum	decrease	 in	 early	diastolic	 velocity	 individually	
and	conducting	parallel	measurement	of	artery	diameter.	
At	present	the	recording	of	long	sequences	of	spectral	wave-
form	with	 the	 option	of	 its	 secondary	 analysis	 is	 possible	
only	when	using	most	 technologically	 advanced	 systems.	
One	should	expect,	however,	that	in	the	nearest	future	the	
technology	of	storing	large	quantities	of	initial	data	will	be	
transferred	 to	 the	 level	 of	middle	 range	 systems,	making	
wider	application	of	the	proposed	solution	possible.
We	 have	 also	 shown	 that	 the	 age-related	 changes	 in	
vasodilation	 assessment	 protocol	 should	 be	 implanted	
in	 cases	when	diabetes	 subjects	 are	 studied.	Diabetes	 is	
often	considered	as	‘vascular	disease’	due	to	its	damaging	
impact	on	vasculature,	thus	proper	use	of	vascular	assess-
ment	methods	 in	 these	group	of	 individuals	 is	 of	utmost	
importance.	
Conclusions
1.		Vascular	 reaction	 to	 the	 administration	 of	 nitric	 oxide	
observed	on	 the	basis	 of	 hemodynamic	 effect	 decreases	
with	age.	
2.		The	 observed	 decrease	 in	 vascular	 reaction	 to	 nitrate	
stimulus	 is	even	more	pronounced	 in	patients	with	dia-
betes	than	in	healthy	individuals.
3.		Vascular	 response	 occurs	 at	 a	 different	 time	 after	 the	
action	of	nitrate	stimulus	both	 in	the	group	at	 low	vas-
cular	 risk	 and	 in	 patients	with	 diabetes,	which	 should	
justify	the	proposed	modification	of	the	pharmacological	
test	protocol.
Figure 3.  NTG Test Dependence of the time of occurrence of the 
reaction and its persistence in group I.
Figure 4.  NTG Test Dependence of the time of occurrence of the 
reaction and its persistence in group II.
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